Diseases that can't be Cured
| Bird-flu crisis plan |
City sees lethal
bug's arrival as inevitable![]() |
|
Infectious-disease experts at the Health Department have been meeting every two weeks to prepare a strategy for protecting the city against diseases such as the Asian bird flu, or H5N1, which many scientists believe is just one crucial mutation away from turning into a monster malady. The written blueprint, which officials expect to complete before the next flu season starts in late fall, spells out how the agency will tackle potentially controversial measures. The issues addressed include how to handle quarantines, test virus samples for new strains, cope with overcrowded hospitals and ration lifesaving vaccines and other treatments. "It's very high on our priority list," said Dr. Isaac Weisfuse, the city's deputy commissioner of disease control who is spearheading New York's pandemic plan. "This is clearly an issue that we're concerned about." Officials are honing the plan as more and more evidence suggests H5N1 is evolving rapidly since it reappeared in Asia with a vengeance in late 2003. The World Health Organization unveiled an alarming report Wednesday indicating the virus is becoming more contagious - from birds to people and possibly even among people. But critics say the city's plan may not go far enough, particularly if it counts on a share of the meager federal stockpile of Tamiflu, the antiviral drug that is the only known treatment against bird flu, also known as avian influenza. "It's irresponsible that we are not stockpiling more of the antivirals," said Rep. Nita Lowey (D-N.Y.), a member of the congressional committee that overseas federal health agencies. "We could really fail to adequately respond if there is a pandemic." Federal authorities have purchased 2.3 million doses of Tamiflu - barely enough to treat 1% of Americans. Antivirals can reduce the severity of an illness and lower the infectiousness of people with the flu. Britain, France and New Zealand have ordered enough Tamiflu to cover up to 20% of their populations, with Canada covering about 17%, according to Roche, the Swiss-based maker. Roche plans to open more plants in the United States by this fall and has fulfilled all orders, company spokesman Terence Hurley said. Even before Britain placed its order, London officials independently bought about 100,000 doses of Tamiflu for its police, fire and transit workers after WHO issued a sobering warning about the growing threat of a pandemic. New York officials said the city has not decided whether to stockpile Tamiflu, and cited major obstacles to stockpiling. Because a pandemic can last up to two years, "we would have to buy a tremendous amount of Tamiflu because you would have to continually give it," Weisfuse said. "You're looking at a fairly major investment." It costs about $2 million for 100,000 doses. Also, there is no consensus among public health officials on how to use antivirals during a pandemic and who should get priority when supplies are limited, Weisfuse said. But independent experts said city officials may be walking a fine line - trying not to upstage federal counterparts, whom they have to lean on in times of crisis. Dr. Martin Blaser, president-elect of the Infectious Diseases Society of America, an association of physicians, agreed that details on how and when to use Tamiflu must be resolved. "But the bottom line is that it is a good idea to stockpile it in some reasonable amount," he said. "Should New York City have its own supply? Probably so." Lowey put it more bluntly: "You can't play nice-nice when it comes to people's health and their lives. States and cities have to take the initiative to protect their own populations." A pilot bird-flu vaccine is in clinical trials at the National Institutes of Health. But large-scale production of any new vaccine would take at least six months once an epidemic breaks out.
KILLER BIRD FLU Q. What is bird flu, or avian influenza? A. A type of flu that normally infects only birds. But sometimes the virus changes and jumps to other species, including pigs and humans. Scientists are calling this strain hitting Asia H5N1. Q. Where and when was H5N1 first detected? A. In Hong Kong in 1997. But it reappeared in Asia in late 2003. Q. How many people have been infected with H5N1 since 2003? A. At least 92, killing 36 Vietnamese, 12 Thais and four Cambodians. Q. How many birds have died of H5N1 or have been culled? A. More than 100 million. Q. How many people have caught H5N1 from other people? A. Scientists have been able to confirm only two cases — involving an 11-year-old Thai girl who infected her mother and aunt. Q. Why are officials so worried about H5N1? A. It is showing signs of mutating into a strain that could cause a worldwide epidemic, or pandemic, in people. It has also been found in pigs, which can carry both human and avian viruses. This means pigs can act as mixing vessels where the two types can swap genes and create virulent new strains. Q. How many flu pandemics have there been in the past century? A. Three. The 1918 Spanish flu killed 20 million to 50 million people. The
1957 Asian flu killed 1 million to 4 million. The 1968 Hong Kong flu killed
about 1 million. All three pandemics were caused by viruses that originated in
birds. |
WORLD
REPORT ON HEALTH
TB Could Make Dangerous Comeback With New Antibiotic Resistant Strains.
Two
separate studies show that multiple-drug-resistant TB,
which can only be cured with a carefully monitored cocktail of drugs, could
start spreading more commonly. The reports, to be published in the journal
Nature Medicine, coincide with another report published last week saying the
World Health Organization's efforts to control multi-drug-resistant TB were not
working as well as hoped. TB could make a dangerous new resurgence with new
strains that are more difficult to fight. TB
infects an estimated 8.7 million people a
year and kills 2 million a year despite widespread control efforts. TB
is making special gains in Eastern Europe and Southeast Asia. TB
strains resistant to several antibiotics are becoming increasingly prevalent,
with "hot spots" in Russia, Eastern Europe, South Africa, China and
Israel.
Source:
·
Hindustan Times, Sep 20, 2004, http://www.hindustantimes.com/news/181_1015333,0050.htm
·
Utusan Online, Sep 19, 2004,
http://www.utusan.com.
U.N.
Warns the Spread of HIV/AIDS Accelerating a Global Tuberculosis Crisis
The
spread of HIV/AIDS is accelerating a tuberculosis crisis that could infect one
billion people in the next 20 years, the U.N. warns. Thirty-five
million people could also die of TB in that time if its growth continues
unchecked, the World Health Organization said during a two-day conference in the
Ethiopian capital, Addis Ababa. The conference is seeking to promote joint
treatment of the two diseases. AIDS kills 8,000 people worldwide each day while
another 5,000 die from TB. TB is the leading killer of people living with
HIV/AIDS. TB infects an estimated 8.7 million people a year and kills 2 million
each year. It is spread by airborne bacteria that settle into the lungs and
cause long-term infection. Many people who are infected do not become ill
themselves but can spread it. The interaction of TB and HIV may evolve into a
global public health crisis compounded by the appearance of drug-resistant TB
strains.
Source:
The United Nations World Health Organization
Major Flu Epidemic Imminent
Overview:
Source: http://www.mosnews.com/news/2004/10/28/pandemic.shtml
Transmission
of Influenza Viruses from Animals to People
Influenza A viruses are found in many different animals, including ducks, chickens, pigs, whales, horses, and seals. Influenza B
viruses circulate widely only among humans. Influenza
A viruses are divided into
subtypes based on two proteins on the surface of the virus: the hemagglutinin
(H) and the neuraminidase (N). There are 15 different hemagglutinin subtypes and
9 different neuraminidase subtypes, all of which have been found among influenza
A viruses
in wild birds. Wild birds are the primary natural reservoir for all subtypes of
influenza A
viruses and are thought to be the source of influenza A
viruses in all other animals. Most influenza viruses cause asymptomatic or mild
infection in birds; however, the range of symptoms in birds varies greatly
depending on the strain of virus. Infection with certain avian influenza A
viruses (for example, some strains of H5 and H7 viruses) can cause widespread
disease and death among some species of wild and especially domestic birds such
as chickens and turkeys. For example,
if a pig were infected with a human influenza virus and an avian influenza virus
at the same time, the viruses could mix (reassort) and produce a new virus that
had most of the genes from the human virus, but a hemagglutinin and/or
neuraminidase from the avian virus. The resulting new virus would likely be able
to infect humans and spread from person to person, but it would have surface
proteins (hemagglutinin and/or neuraminidase) not previously seen in influenza
viruses that infect humans. This type of major change in the influenza A
viruses is known as antigenic shift. Antigenic shift results when a new
influenza A
subtype to which most people have little or no immune protection infects humans.
If this new virus causes illness in people and can be transmitted easily from
person to person, an influenza pandemic can occur. How
the Flu Virus Can Change - "Drift" and "Shift"
Influenza
viruses can change in two different ways. Antigenic shift is an
abrupt, major change in the influenza A viruses, resulting in new hemagglutinin
and/or new hemagglutinin and neuraminidase proteins in influenza viruses that
infect humans. Shift
results in a new influenza A
subtype. When shift happens,
most people have little or no protection against the new virus. While influenza
viruses are changing by antigenic drift all the time, antigenic shift happens
only occasionally. Type A viruses undergo both kinds of changes; influenza type
B viruses change only by the more gradual process of antigenic drift. More
Information
HHS:
National Vaccine Program Office (NVPO), Pandemic Influenza Information |
Flesh-eating germ death
Bronx girl, 10, can't fight off strep bacteria
A 10-year-old Bronx public school student was killed by a rare flesh-eating bacteria - devastating her family and alarming her classmates' parents.
Fifth-grader Nathera Masoud, who had never suffered any serious health problems, was overcome by a fast-moving, invasive form of group A streptococcus that took her promising
young life Friday. "She was so strong," her heartbroken mother Daisy Masoud told the Daily News yesterday, the day after funeral services for the vivacious little girl, who loved science and music.
"She fought it, but there was nothing she could do. ... She was a wonderful kid."
Nathera was a victim of an often deadly condition called necrotizing fasciitis, in which the bacteria eats away at human tissue with frightening speed. The girl may have been particularly susceptible because she had eczema, a skin condition, doctors told her mother.
Group A streptococcus is the same bacteria that causes common strep throat and scarlet fever, which can be treated with antibiotics. But necrotizing fasciitis, its most invasive form, can prove deadly - killing 100 to 300 people in the U.S. annually - even when swiftly treated.
School officials sent a letter home to parents at Public School/Middle School 95 near Van Cortlandt Park, assuring them the disease that killed Nathera is rare and not spread through casual contact.
Officials said there was no need for students to get antibiotics to prevent infections.
Still, shaken parents at the 1,500-student Hillman Ave. school said they had deep concerns and questions about the tragedy.
"I can't help but worry," said Linda Colon, whose son is in the same third-grade class as Nathera's brother. "They informed us and everything, but I still worry."
The letter home urged parents to tell their children to wash their hands with soap and water.
"They say the kids should wash their hands but then my son tells me, 'Mommy, they don't have any soap at school,'" said Linda Rivera, mother of another third-grader. "So I'd like for them to get some soap."
The school scheduled a parents meeting for tomorrow at 6p.m.
Nathera first started feeling ill around April 2, as she was exhibiting her science project at Lehman College, after winning a science competition, her mother said. The girl complained about a sharp pain in her arm, near her armpit. She had recurring diarrhea and was listless, not even getting up to play when her cousins visited. After several days, the pain in her arm intensified.
Her temperature hit 103.8 degrees on April 8 and she went to a doctor, who gave her Motrin and Tylenol, her mother said.
But the arm pain spread toward her collar bone.
On April 10, Nathera's family sought help at Montefiore Medical Center's emergency room, but left after waiting five frustrating hours without seeing a doctor, her mother said.
"She was in such pain and she had trouble describing it," Daisy Masoud said. "She said it was an extremely squeezing, pushing pain."
Nathera stayed home from school the next day, but went in on April 12 to take the citywide fifth-grade reading test. The school nurse noticed something was wrong and told Daisy Masoud to get Nathera immediately to a doctor.
Within hours, the girl was in Montefiore undergoing tests, including a biopsy that confirmed her tissues were under attack from the bacteria.
Three days later, Nathera was dead.
Family and friends sought comfort in memories of Nathera as an energetic and fun-loving girl who loved school and listening to Hilary Duff songs.
"She was a lovely girl and will be greatly missed by her school family," said Elizabeth Lopez, the principal of PS/MS 95.
With Bill Egbert
Rare strain under the microscope
It's a bacteria commonly found in the throat and on the skin.
Source: City Health Dept